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Abstract 
Rationale: Cigarette smoking is a well-established risk factor for myocardial infarction and sudden 
cardiac death. The deleterious effects are mainly due to nicotine, but the mechanisms involved and 
theranostics remain unclear. Thus, we tested the hypothesis that nicotine exposure increases the heart 
sensitivity to ischemia/reperfusion injury and dysfunction, which can be rescued by autophagy inhibitor.  
Methods: Nicotine or saline was administered to adult rats via subcutaneous osmotic minipumps in the 
absence or presence of an autophagy inhibitor, 3-methyladenine (3-MA). After 30 days of nicotine 
treatment, the rats underwent the cardiac ischemia/reperfusion (I/R) procedure and echocardiography 
analysis, and the heart tissues were isolated for molecular biological studies.  
Results: Nicotine exposure increased I/R-induced cardiac injury and cardiac dysfunction as compared to 
the control. The levels of autophagy-related proteins including LC3 II, P62, Beclin1, and Atg5 were 
upregulated in the reperfused hearts isolated from nicotine-treated group. In addition, nicotine enhanced 
cardiac and plasma ROS production, and increased the phosphorylation of GSK3β (ser9) in the left 
ventricle tissues. Treatment with 3-MA abolished nicotine-mediated increase in the levels of 
autophagy-related proteins and phosphorylation of GSK3β, but had no effect on ROS production. Of 
importance, 3-MA ameliorated the augmented I/R-induced cardiac injury and dysfunction in the 
nicotine-treated group as compared to the control.  
Conclusion: Our results demonstrate that nicotine exposure enhances autophagy signaling pathway, 
resulting in development of ischemic-sensitive phenotype of heart. It suggests a potentially novel 
therapeutic strategy of autophagy inhibition for the treatment of ischemic heart disease. 
Key words: nicotine, cardiac ischemia/reperfusion injury, autophagy pathway  
Introduction 
Nicotine exposure, either from tobacco cigarette 
smoking or nicotine use (nicotine gum or patch) has 
become one of the most pressing public concerns in 
modern life. Furthermore, electronic cigarette 
(e-cigarette), an electronic nicotine delivery system 
has been introduced in the global market during the 
past ten years. Thus, nicotine addiction and nicotine 
abuse are becoming a potential public health concern 
in the 21st century. Epidemiologic studies have shown 
that cigarette smoking is the most prominent risk 
factor for coronary heart disease and cardiovascular 
mortality in the general population [1-4]. Although 
cigarette smoke contains thousands of chemicals, 
nicotine and its metabolites are recognized as being 
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the major psychoactive compounds and are likely to 
contribute to the development of cardiovascular 
disorders. Indeed, clinical and animal studies have 
suggested that cigarette smoking-induced myocardial 
ischemia is mediated by nicotine [5-7]. However, 
underlying mechanisms of cardiac dysfunction 
induced by nicotine exposure are largely unknown 
and the specific pathophysiologic pathways leading 
to the development of heart ischemic-sensitive 
phenotype remain to be identified.  
Autophagy is a cellular process associated with 
unnecessary protein damage and organelle 
degradation. Autophagy functions as a protein 
quality controller and cellular homeostasis keeper [8]. 
In the heart, autophagy occurs constitutively at a 
basal level [9], but is enhanced during pathological 
conditions, including cardiac hypertrophy, 
cardiomyopathy, ischemic heart disease and heart 
failure [10]. However, the role of autophagy in 
ischemic heart injury is controversial and complex 
[11]. Whether autophagy is protective or detrimental 
is context-dependent. In general, a modest increase in 
autophagy under ischemic stress appears to be 
protective, whereas massive activation may be 
detrimental and induce type 2 cell death 
(autophagy-induced cell death), which contributes to 
ischemic cardiac injury [12]. Previous studies have 
shown that cigarette smoke and nicotine exposure 
cause different tissue and cell damage via activation 
of autophagy pathway [13-16]. This led us to 
contemplate if chronic nicotine exposure alters the 
homeostatic autophagy process and exert adverse 
effects in cardiomyocytes.  
Therefore, in the present study we first evaluated 
whether chronic nicotine exposure increased the heart 
susceptibility to ischemia/reperfusion (I/R) injury 
and decreased heart functional recovery after I/R 
injury. Next, we examined whether chronic nicotine 
exposure enhanced autophagy-related biomarkers in 
cardiomyocytes. Finally, we assessed the effect of 
therapeutic inhibition of autophagy activation on 
nicotine-mediated cardiac ischemic injury and 
dysfunction to test the hypothesis that nicotine- 
mediated autophagy plays a causal role in the 
development of heart ischemic-sensitive phenotype in 
an adult rat model. Our findings suggest that auto-
phagy may be a potential therapeutic molecular target 
for the treatment of cardiovascular ischemic disease. 
Methods 
Experimental animals 
The procedures and protocols were approved by 
the Institutional Animal Care and Use Committee of 
Loma Linda University. All animal studies followed 
the guidelines in the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals. 
Sprague-Dawley male rats (8-months-old) were 
purchased from Charles River Laboratories (Portage, 
MI) and housed individually in Plexiglas acrylic 
cages, located in air-conditioned rooms (room 
temperature 22℃, relative humidity 60%; lights on 
from 8:00 a.m. to 8:00 p.m.). Pellet food and tap water 
were available ad libitum. Rats were anesthetized with 
isoflurane (5% for induction, 2% for maintenance) and 
adequate anesthesia was determined by the loss of 
pedal withdrawal reflex and other reactions from the 
animals in response to pinching the toe or tail. Saline 
or nicotine (at 4 µg/kg/min) were individually 
administered to rats through osmotic minipumps 
(type 2ML4, Alzet, Durect Corp., Cupertino, CA) and 
inserted under the skin on the back of rats for 30 days, 
as previously described in detail [17-19]. The dose of 
nicotine resulted in blood levels closely resembling 
those occurring in moderate human smokers [20]. A 
total of 45 rats were used in this project and were 
randomly divided into four groups: 1) saline control 
(n=13); 2) nicotine (n=10); 3) saline + 3-MA (n=11); 
and 4) nicotine + 3-MA (n=11). One week before I/R 
surgery, 3-methyladenine (3-MA) (15 mg/kg/day; 
Sigma Aldrich, St. Louis, MO) or saline was 
respectively administered to rats via intraperitoneal 
(i.p.) injection for seven days. Previous studies have 
shown that treatment with this dosage of 3-MA 
significantly inhibits autophagy signaling [21, 22]. To 
separate the confound effect of sex, in this study we 
only selected male rats in the proposed experiments. 
In our future studies, we will investigate the effect of 
nicotine on female rats. 
Echocardiography 
To measure LV function and heart chamber 
dimensions in the four groups of animals, 
echocardiography was performed with LOGIQ e 
Ultrasound (GE Medical System) as previously 
described [23]. Briefly, the rats were anesthetized with 
2% isoflurane, the chest was shaved, and a layer of 
acoustic-coupling gel was applied to the thorax. Then 
the rats were placed in the left lateral decubitus 
position. M-mode recording of the LV was obtained at 
the level of the mitral valve in the parasternal view 
using two-dimensional (2D) echocardiographic 
guidance in both short and long axis views. Cardiac 
function and heart dimensions were evaluated by 2D 
echocardiography on the anesthetized (2% isoflurane) 
rat. M-mode tracing was used to measure functional 
parameters such as LV end-diastolic dimension 
(LVEDD), LV end-systolic dimension (LVESD), LV 
end-diastolic volume (LVEDV) and LV end-systolic 
volume (LVESV) were calculated using the above 
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primary measurements and accompanying software. 
The percentage of LV ejection fraction (EF) was 
calculated as (LVEDV-LVESV)/LVEDV x 100% and 
the percentage of LV fractional shortening (FS) was 
calculated as (LVEDD-LVESD)/LVEDD x 100%. 
Echocardiography data were recorded and analyzed 
blindly to the different treatments. 
Myocardial I/R injury model 
After 30 days of nicotine treatment, the rats were 
subjected to ischemia/reperfusion (I/R) procedure in 
vivo as described previously [24, 25]. Briefly, rats were 
anaesthetized with 2% isoflurane and placed on the 
RoVent Jr. Small Animal Ventilator (Kent Scientific). 
Ischemia was induced by an occlusion on left anterior 
descending (LAD) coronary artery for 45 mins. 
Reperfusion was initiated after 45 mins of ischemia. 
Myocardial reperfusion was confirmed by changes in 
the appearance of the heart from pale to bright red. 
After 24 hours of reperfusion, some of the rats from 
each group were anesthetized. Their hearts were 
rapidly removed and serially sectioned along the 
short axis in 2-mm-thick sections. To measure the 
infarct size, the slices were then incubated in 2% 
2,3,5-triphenyltetrazolium chloride (TTC) solution for 
ten minutes at 37°C and immersed in formalin for 30 
minutes. Viable tissue stained red, while nonviable 
tissue remained white. The infarct size and the area of 
LV in each slice were analyzed by computerized 
planimetry (NIH image J software), corrected for the 
tissue weight, summed for each heart, and expressed 
as a percentage of the total left ventricle weight.  
Masson’s trichrome staining 
Masson’s trichrome staining is widely used to 
study cardiac pathologies including cardiac infarction 
and fibrosis. In the present study, the heart was 
rapidly excised, rinsed to remove blood. Then, the 
heart tissues were cryopreserved by using optimal 
cutting temperature (OCT) tissue medium and 
sectioned transversely from the basal part to the apex 
of left ventricle using a cryostat with 10 µm thickness. 
Masson’s Trichrome staining (Abcam) was performed 
according to the manufacture’s instruction to quantify 
infarct scar size (blue staining). The infarct scar size 
was analyzed by computerized planimetry and 
expressed as the ratio of scar area to total LV area.  
Measurement of superoxide production in 
heart tissues 
The oxidative fluorescent dye hydroethidium 
(HE) was used to evaluate superoxide production in 
situ, as described previously [19, 26]. Briefly, unfixed 
frozen heart segments were cut into 10-µm thick 
sections using Leica CM 3050S cryostat at -20℃. The 
middle slice sections of LV were used and each tissue 
slides was incubated with HE (5 µM) at 37 ℃ for 30 
minutes. Fluorescence in LV sections was obtained 
with an EVOS FL color imaging system (Life 
Technologies Corp. Carlsbad, CA). The quantitative 
analysis of HE fluorescence intensity was analyzed 
using the NIH Image J software.  
Measurement of reactive oxygen species 
(ROS) production in plasma 
Plasma was collected from the rat after seven 
days of reperfusion. The total ROS levels in the 
plasma were measured with the OxiselectTM in vitro 
ROS/RNS assay kit (Cell Biolabs, Inc. San Diego, CA), 
following the manufacturer’s instruction and 
described previously [19, 27]. Briefly, 50 µL of the 
plasma samples or standard were added to a 96-well 
plate and mixed with 50 µL of catalyst and 100 µL of 
2’,7’-dichlorodihydrofluorescein diacetate (DCF). 
After incubation at room temperature for 30 minutes, 
the fluorescence (Ex480nm/Em530nm) was measured 
using a Synergy HT Multi-Mode Microplate Reader 
(Bio-Tek Instruments, Inc., Winooski, VT, USA). 
Western immunoblotting 
Protein abundance in heart was measured as 
previously described [28]. Briefly, the middle slices of 
LV tissues were isolated and homogenized in a lysis 
buffer followed by centrifugation at 4℃ for 20 
minutes at 10000g, and the supernatants were 
collected. Samples with equal proteins were loaded 
onto 7.5% polyacrylamide gel with 0.1% sodium 
dodecyl sulfate and separated by electrophoresis at 
100 V for two hours. Proteins were then transferred 
onto nitrocellulose membranes and incubated with 
primary antibodies against LC3 (Cell Signaling 
Technology), Beclin-1 (Cell Signaling Technology), 
p62 (Cell Signaling Technology), Atg5 (Cell Signaling 
Technology), GSK3β (Cell Signaling Technology), 
p-GSK3β (Cell Signaling Technology), respectively. 
After washing, membranes were incubated with 
secondary horseradish peroxidase-conjugated 
antibodies. Proteins were visualized with enhanced 
chemiluminescence reagents, and blots were exposed 
to Hyperfilm. Results were quantified with the Kodak 
electrophoresis documentation and analysis system 
and Kodak ID image analysis software (Kodak, 
Rochester, NY). The target protein abundance was 
normalized to the abundance of GAPDH as a protein 
loading control.  
Statistical analysis 
All data are expressed as the mean ± SEM 
obtained from the number (n) of experimental 
animals given. Differences between the groups were 
compared by Student’s t-test or analysis of variance 
(ANOVA) using the Graph-Pad Prism software 
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(GraphPad Software Version 4, San Diego, CA, USA), 
where appropriate. For all comparisons, P-values less 
than 0.05 indicated statistical significance. 
Results 
Effects of chronic nicotine exposure on 
I/R-induced myocardial infarction and heart 
function 
Chronic nicotine treatment for 30 days had no 
effect on the body weights of rats (data not shown). 
Similarly, there was no significant difference in the 
ratio of heart to body weight between the saline 
control and nicotine-treated groups (data not shown). 
As shown in Fig. 1, after 45 minutes of ischemia 
followed by 24 hours of reperfusion, there was a 
remarkable increase in myocardial infarction in rats. 
In the absence of autophagy inhibitor Methyladenine 
(3-MA), chronic nicotine exposure induced a 
significant increase in myocardial infarct size as 
compared with the saline control group under I/R 
procedure (Fig. 1). However, in the presence of 3-MA 
(Fig. 1), 3-MA treatment eliminated the difference of 
infarct size between the saline control and 
nicotine-treated group under I/R procedure. As 
shown in Fig. 2, the cardiac scar size after seven days 
of reperfusion was significantly higher in the 
nicotine-treated group than the saline control group 
in the absence of 3-MA (P < 0.05). However, treatment 
with 3-MA had the trend to attenuate 
nicotine-mediated cardiac scar size but did not 
reached significance under I/R procedure (Fig. 2). 
Fig. 3 shows typical echocardiographic images at 
different time periods in both saline control and 
nicotine-treated groups in the absence and presence of 
3-MA treatment. Fig. 4 shows the summary data 
obtained from the echocardiography analysis. As 
shown in Fig 4, there were no significant differences 
of left ventricular end-diastolic dimension (LVEDD), 
LV end-systolic dimension (LVESD), ejection fraction 
(EF) and fractional shortening (FS) at baseline and at 
30 days of nicotine treatment between the saline 
control and nicotine-treated groups. However, after 
ischemia/reperfusion (I/R), the values of LVEDD 
(Fig. 4A) and LVESD (Fig. 4C) were reperfusion 
time-dependently increased. In addition, the values of 
EF (Fig. 4E) and FS (Fig. 4G) were reperfusion 
time-dependently decreased in nicotine-treated 
animals as compared to the saline control animals 
under I/R procedure. More importantly, treatment 
with autophagy inhibitor, 3-MA, abolished the 
nicotine-mediated changes of LVEDD (Fig. 4B), 
LVESD (Fig. 4D), EF (Fig. 4F), and FS (Fig. 4H) in the 
animals under I/R procedure.  
 
Figure 1. Nicotine exacerbates on ischemia/reperfusion (I/R)-induced 
myocardial infarct size and 3-MA reduces it. Rats from each group were 
subjected to 45 min of heart ischemia followed by 24 hours of reperfusion. After I/R, 
the hearts were isolated and their infarct sizes in each rat group were determined 
with 2% TTC staining (A). The bar graph (B) showing left ventricle infarct size (infarct 
area/total LV area) in each rat group. Data are means ± SEM of animals from each 
group (n=4-5) were analyzed by 2-way ANOVA. *P < 0.05 versus saline control. 
 
Figure 2. Nicotine enhances ischemia/reperfusion (I/R)-induced relative 
myocardial scar area. Rats from each group were subjected to 45 min of heart 
ischemia followed by seven days of reperfusion. After I/R, the hearts were isolated 
and their relative scar areas in each rat group were determined with Masson’s 
trichrome staining (A) as described in the Methods section. The bar graph (B) 
showing left ventricle scar size (ratio of scar area to total LV area) in each rat group. 
Data are means ± SEM of animals from each group (n=4-5) were analyzed by 2-way 
ANOVA. *P < 0.05 versus saline control. 
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Figure 3. Echocardiographic evaluation of cardiac function. Rats were administered with either saline or nicotine for 30 days. Seven days before I/R surgery, 3-MA or 
saline was administered to rats as described in Methods section. The representative echocardiographic images were obtained from different time periods including at baseline, 
30 days of nicotine treatment, one day after I/R, and seven days after I/R. The red arrow represents LV end-systolic dimension (LVESD) and the blue arrow represents LV 
end-diastolic dimension (LVEDD).  
 
Effects of chronic nicotine exposure on 
autophagy-associated biomarkers  
Chronic nicotine exposure significantly 
enhanced the LC3 II/LC3 I protein expression ratio 
(Fig. 5A) and p62 protein expression levels (Fig. 5C) in 
the LV tissues as compared with saline control group 
in the absence of 3-MA under I/R procedure. 
However, in the presence of 3-MA, the ratio of LC3 
II/LC3 I protein (Fig 5B) and the levels of p62 protein 
(Fig. 5D) in the LV tissues were not significantly 
different between the saline control and 
nicotine-treated rats under I/R procedure. Similarly, 
the protein levels of Beclin 1 (Fig. 6A) and Atg5 (Fig. 
6C) in the LV tissues were higher in the nicotine- 
treated rats than those in the saline control group, and 
3-MA treatment also eliminated these differences 
between the saline control and nicotine exposed 
groups under I/R procedure (Fig. 6B and 6D). 
Effects of chronic nicotine exposure on 
reactive oxygen species (ROS) production  
To determine whether chronic nicotine exposure 
causes oxidative damage in the heart, production of 
superoxide anion (O2-) was assessed by the oxidative 
fluorescent dye HE. As shown in Fig. 7A and B, 
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chronic nicotine exposure increased the production of 
O2- in the LV tissues as compared with the saline 
control groups in the absence of 3-MA under I/R 
procedure. Interestingly, 3-MA treatment did not 
affect nicotine-mediated increase in O2- production 
under I/R procedure. In addition, we determined the 
ROS production in the plasma using a ROS assay kit 
under I/R procedure. As shown in Fig. 7C, the plasma 
ROS levels in the nicotine-treated animals were 
substantially higher than those in the saline control 
animals, and 3-MA treatment had no effect on 
nicotine-mediated ROS production in the plasma. 
 
 
Figure 4. Effects of nicotine exposure on cardiac function before and after I/R. The echocardiographic data of both the saline control and nicotine-treated groups 
were examined at following time periods: before nicotine treatment (baseline), 30 days of nicotine treatment, one day after I/R, and seven days after I/R. The summary data 
include: left ventricular end-diastolic dimension (LVEDD) in the absence (A) and in the presence of (B) 3-MA treatment; left ventricular end-systolic dimension (LVESD) in the 
absence (C) and in the presence of (D) 3-MA treatment; percent of ejection fraction (EF%) in the absence (E) and in the presence of (F) 3-MA treatment; percent of fractional 
shortening (FS%) in the absence (G) and in the presence of (H) 3-MA treatment. Data are means ± SEM of animals from each group (n=4-5) were analyzed by 2-way ANOVA. 
*P < 0.05 versus saline control. 
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Figure 5. Effects of nicotine exposure on the protein expressions of LC3 II/LC3 I and p62. Rats from each group were subjected to 45 minutes of heart ischemia and 
seven days of reperfusion. After I/R, the hearts were isolated and the protein abundance in the left ventricle tissue was determined by Western blot analysis. LC3 II/LC3 I protein 
density in the absence of 3-MA (A) and in the presence of 3-MA (B) treatment. p62 protein density in the absence of 3-MA (C) and in the presence of 3-MA (D) treatment. Data 
are means ± SEM (n=4 animals/groups). *P < 0.05 vs. control, as determined by Student’s t-test. 
 
Effects of chronic nicotine exposure on cardiac 
glycogen synthase kinase 3 beta (GSK3β) 
activity  
GSK3β is a master regulator of cardiac cell 
growth and death, which is highly involved in the 
setting of heart ischemic injury. To investigate the role 
of GSK3β signaling in mediating cardiac dysfunction 
in response to nicotine exposure, the phosphorylation 
levels of GSK3β at serine 9 and total GSK3β protein 
expression were determined by Western blot analysis. 
As shown in Fig. 8, chronic nicotine exposure had no 
significant effect on GSK3β protein expression, but 
enhanced the ratio of serine 9 phosphorylation of 
GSK3β to total GSK3β protein expression in the LV 
tissues as compared with the control groups under 
I/R procedure. In addition, 3-MA treatment 
eliminated the difference of the ratio of serine 9 
phosphorylation of GSK3β to total GSK3β protein 
expression between the control and nicotine-treated 
animals under I/R procedure. 
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Discussion 
Epidemiological and animal studies have shown 
that tobacco smoking increases the risk of ischemic 
heart disease [3, 29], and suggest that nicotine 
contributes to myocardial ischemia [3]. The present 
study provides further direct evidence that chronic 
nicotine exposure increases myocardial infarct size 
and heart dysfunction in a rat model of 
ischemia/reperfusion. The major findings in the 
present study are: (1) chronic nicotine exposure 
increased cardiac I/R injury and resulted in cardiac 
dysfunction in vivo, which was associated with a 
significant increase in autophagy biomarkers, 
oxidative stress-related ROS, and ischemia-related 
protein GSK3β; (2) inhibition of autophagy with an 
autophagy inhibitor normalized the aberrant 
autophagy level and reversed the increased 
vulnerability to heart I/R injury and dysfunction. 
These findings suggest a potentially novel therapeutic 
strategy of anti-autophagy for the treatment of 
smoking/nicotine-mediated heart ischemic disease. 
 
 
Figure 6. Effects of nicotine exposure on the protein expressions of Beclin1 and Atg5. Rats from each group were subjected to 45 minutes of heart ischemia and 
seven days of reperfusion. After I/R, the hearts were isolated and the protein abundance in the left ventricle tissue was determined by Western blot analysis. Beclin 1 protein 
density in the absence of 3-MA (A) and in the presence of 3-MA (B) treatment. Atg5 protein density in the absence of 3-MA (C) and in the presence of 3-MA (D) treatment. Data 
are means ± SEM (n=4 animals/groups). *P < 0.05 vs. control, as determined by Student’s t-test. 
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Figure 7. Effects of nicotine exposure on cardiac and plasma ROS production. Rats from each group were subjected to 45 minutes of heart ischemia and seven days 
of reperfusion. After I/R, plasma from each rat was collected and LV segments were cut into 10-µm thick sections as described in Methods section. HE fluorescence from each 
LV section was used to image (A) and analyze ROS production (B) in situ in the absence and presence of 3-MA. Plasma ROS levels were measured using in vitro ROS/RNS assay 
kit (C). Data are means ± SEM of tissue from 4 animals from each group. Scale bar is 50 µm. *P < 0.05 versus saline control, as determined by Student’s t-test.  
 
 Our data indicated that the ratio of heart weight 
to body weight was not changed between the control 
and nicotine-treated groups. In addition, although we 
did not measure the ratio of heart weight/body 
weight after seven days of reperfusion, our 
echocardiographic observations indicated that there 
were no differences of LVPWd (data not shown) 
between the nicotine-treated and control groups. 
These data suggest that nicotine does not induce 
cardiac hypertrophy at both resting and 
I/R-challenged condition. The present study showed 
that chronic nicotine exposure had no significant 
effect on pre-ischemic baseline values of heart 
function determined by echocardiography but 
significantly increased LV myocardial infarct size and 
impaired LV function after ischemia/reperfusion in 
rats. The data suggests that chronic nicotine exposure 
does not affect heart function at normal physiologic 
conditions but alters the heart function when it 
encounters an ischemic stress challenge. Previous 
studies in human and animal models have reported 
that cigarette smoking is one of the top risk factors of 
ischemic heart disease [3, 4, 6, 29]. Furthermore, there 
were positive relations between smoking-mediated 
myocardial infarct size and nicotine concentration in 
the animal model [3]. The present findings that 
chronic nicotine exposure enhanced I/R-induced 
myocardial infarct and scar size, suggest that nicotine 
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is a key factor in cigarette smoking-induced cardiac 
infarction and heart dysfunction. As a ganglionic 
agonist, nicotine can bind the nicotinic Ach receptor 
and stimulate neurotransmitter, catecholamine 
release. Previous studies have demonstrated that 
cigarette smoking significantly increases plasma 
norepinephrine and epinephrine levels, which are 
stimulated by nicotine [5, 6]. Increased circulating 
concentrations of catecholamines enhance the pulse 
rate, blood pressure, and ischemic heart injury [5, 6, 
28]. Therefore, it is likely that cigarette 
smoking/nicotine exposure-associated increments in 
ischemic heart infarction are mediated through 
adrenergic mechanisms by releasing catecholamine. 
Indeed, our previous studies in a similar pregnant rat 
model have demonstrated that maternal nicotine 
exposure during pregnancy enhances norepinephrine 
levels in the fetal heart, resulting in development of 
heart ischemia-sensitive phenotype [30].  
The molecular mechanisms underlying 
nicotine-mediated increase in ischemic injury and 
heart dysfunction are still largely unknown. In the 
present study, we observed that chronic nicotine 
exposure enhanced autophagy biomarkers (such as 
LC3II, p62, Beclin 1, and Atg 5) protein abundance in 
cardiac tissues. Consistent with our observation, other 
studies have shown that nicotine exposure increases 
autophagy activation in human fibroblast cells [31], 
human cancer colon cells [32], and bronchial epithelial 
cells [13]. These findings suggest that nicotine is one 
of the key activators of autophagy. Growing evidence 
has shown an important role of autophagy in the 
pathophysiological process of ischemic heart injury 
[33]. However, whether autophagy serves a beneficial 
or detrimental role in the myocardium depends on the 
level of autophagy activation and the context in which 
it is induced [8, 10, 11]. It has been reported that 
upregulation of autophagy in the setting of mild 
ischemia provides a protective effect that promotes 
functional recovery of the heart. However, there is 
also strong evidence that excessive autophagy 
contributes to myocyte death and heart dysfunction 
[11]. Our present findings that treatment with 3-MA 
significantly inhibited nicotine-mediated autophagy 
and eliminated the difference of I/R-induced cardiac 
injury and dysfunction between the saline control and 
nicotine-treated rats, suggest that nicotine-mediated 
heightened autophagy is one of the key molecular 
mechanisms contributing to ischemic heart injury and 
dysfunction. Consistent with our findings, a previous 
study has shown that enhanced autophagy leads to 
accumulation of autophagosomes and cardiac 
contractile dysfunction, and inhibition of autophagy 
with 3-MA treatment prevents heart injury [34]. In 
addition, other studies in rat primary cardiac 
myocytes in vitro have demonstrated that treatment of 
3-MA or knockdown of Beclin 1 inhibits ischemia/ 
reperfusion-induced autophagy, leading to reduced 
cardiac injury and enhanced cardiac myocyte survival 
[35]. In contrast to these finding, our current data (Fig. 
1 and 2) indicated that in vivo treatment of 3-MA had 
no effect on I/R-induced heart injury in saline control 
animals. This discrepant effect of 3-MA between in 
vitro cardiac myocytes and in vivo heart may suggest 
 
 
Figure 8. Effects of nicotine exposure on the protein expressions of total GSK3β and phosphorylation of GSK3β (ser9). Rats from each group were subjected 
to 45 minutes of heart ischemia and seven days of reperfusion. After I/R, the hearts were isolated. The protein abundances of p-GSK3β and total GSK3β in the left ventricle 
tissues were determined in the absence of 3-MA and in the presence of 3-MA. Data are means ± SEM (n=4 animals/groups). *P < 0.05 vs. control, as determined by Student’s 
t-test. 
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that basal autophagy dose not play a key role in 
I/R-induced heart injury in animals at physiologic 
condition. However, our present findings that that 
treatment with 3-MA significantly inhibited I/R- 
induced heart infarct size in nicotine-treated animals 
and eliminated the difference of I/R-induced cardiac 
infarct size and dysfunction between the saline 
control and nicotine-treated rats, suggest that the 
excess of autophagy plays an important role in 
nicotine-mediated I/R-induced heart ischemic injury 
and dysfunction. Taken together, our current findings 
with others suggest a causal effect of autophagy in the 
setting of ischemic heart injury and dysfunction under 
pathologic condition. In addition, we need keep in 
mind that autophagy signaling pathway may be not 
the only signaling pathway involved nicotine- 
mediated cardiac dysfunction, other signaling path-
ways such as apoptosis may also be involved.  
The process of autophagy is complex and mainly 
comprised of the following stages: initiation, 
nucleation, expansion, maturation, and degradation. 
Numerous autophagy-related (Atg) genes and 
signaling molecules have been identified and are 
sequentially activated to regulate different stages of 
autophagy. There are three classes of PtdIns3K and 
phosphatidylinositol 3-Kinases (PI3Ks) involved in 
the regulation of autophagy. Class I PI3K responds to 
growth factor signaling and produces PtdIns(3,4,5)P3 
that negatively regulates autophagy via the 
AKT-mTOR complex, whereas the class III PI3K, as 
well as class II PI3K, contributes to the initiation and 
progression of autophagy. Beclin 1 is one of the major 
genes involved in the class III PI3K complex signaling 
[36]. The formation of autophagosome is often 
initiated with Beclin1 as an internal stimulus followed 
by several autophagy related proteins including Atg5 
[37]. In the present study, our data indicated that 
nicotine exposure enhanced the protein levels of 
Beclin1 and Atg5 in the LV tissues, which were 
reversed by the treatment of 3-MA. Consistent with 
our findings, previous studies demonstrated that 
cigarette smoking induces autophagy via increasing 
Beclin1 and Atg5 gene expressions [38]. These data 
suggest that activation of the class III PI3K signaling 
pathway is one of the important mechanisms 
underlying nicotine-induced cardiac autophagy. In 
addition to the regulation of class III PI3K pathway, 
our present findings that nicotine exposure 
significantly increased p62 protein levels in ischemic 
heart tissues, which was abrogated by 3-MA 
treatment, suggest that p62 also play a key role in 
nicotine-mediated autophagy. Similarly, previous 
studies have demonstrated that nicotine increases 
co-expression of impaired autophagy marker, 
SQSTM1/p62 and ubiquitin [13]. It is well known that 
ubiquitinated cargo including injury organelles and 
potentially toxic protein aggregates is delivered to 
autophagosomes by the receptor protein p62 [39, 40]. 
The interaction between autophagosomes and 
SQSTM1/p62 has been observed in smokers’ alveolar 
macrophages [41]. The formation of autophagosome 
is often initiated with Beclin1 as an internal stimulus 
followed by several autophagy related proteins 
including Atg5 [37]. Thus, we speculate that Beclin 
1/Atg5/p62/LC3II signaling may be one of the major 
signaling pathways underlying nicotine-mediated 
autophagy and ischemic heart injury.  
It has been shown that cigarette smoking 
increases the sensitivity of hearts to ischemia/ 
reperfusion injury associated with increased 
production of oxygen free radicals [42]. Consistent 
with this study, our present study also showed an 
increase in ROS production in both plasma and 
cardiac tissue of the rat exposed to nicotine. Further-
more, our previous studies have demonstrated that 
inhibition of ROS reverses perinatal nicotine- 
mediated ischemic heart injury and heart dysfunction 
[43]. These studies suggest that oxidative stress plays 
a key role in the aberrant development of heart 
ischemia-sensitive phenotype in response to cigarette 
smoking/nicotine exposure. The relationship between 
ROS and autophagy has been demonstrated in several 
other systems [44, 45], but the cause-and-effect 
relation is controversial. For example, amino acid 
deprivation induces the formation of ROS in 
mitochondria in a Class III PI3K-dependent manner 
[45]. On the contrary, p62 overexpression increases 
ROS and accelerates tumorigenesis [46]. Although 
molecular mechanisms underlying nicotine-induced 
excessive autophagy in the heart are not fully 
understood, previous studies have shown that 
stress-induced ROS is essential for the induction of 
autophagy [45]. We speculate that nicotine-mediated 
ROS release may be one of the key mechanism 
underlying nicotine-induced excessive autophagy. 
Indeed, our current study found that 3-MA treatment 
did not affect nicotine-mediated ROS production. 
Consistent with our finding, previous studies have 
also demonstrated that 3-MA has no effect on ROS 
production in starvation-induced or dexamethasone- 
induced autophagy [47]. These findings suggest that 
ROS is the up-stream signaling of autophagy in our 
animal model. Future studies are needed to employ a 
specific ROS scavenger or antioxidant to confirm 
whether the heightened ROS is one of the key 
mechanisms underlying nicotine-induced autophagy. 
GSK3β gene plays a significant role in embryonic 
cardiomyocyte development. Recent studies 
demonstrate a functional role of GSK3β in negative 
modulation of cardiac hypertrophy and in the setting 
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of cardiac ischemic disease [48-50]. GSK3β is a unique 
protein kinase. The dephosphorylated GSK3β is in 
active form, but GSK3β will be inactivated when it is 
phosphorylated at the serine 9 residue by other factors 
[51, 52]. In present study, we demonstrated that 
chronic nicotine exposure enhanced the phosphoryla-
tion levels of GSK3β at the serine 9 residue as 
compared to the saline controls. This suggests that the 
enhanced phosphorylation of GSK3β may lead to a 
decrease in cardiac GSK3β activity. In addition, our 
present data that treatment of 3-MA eliminated the 
difference of the phosphorylation level of GSK3β 
between the saline control and nicotine-treated 
animals, suggests that the enhanced phosphorylation 
of GSK3β is at least partially regulated through an 
autophagy-dependent signaling pathway. 
In summary, the present study provides new 
evidence that excess autophagy is one of the key 
molecular signaling linkers between nicotine 
exposure and the development of the heart 
ischemic-sensitive phenotype. Our data indicated that 
nicotine exposure stimulated oxidative stress and 
enhanced cardiac autophagy biomarkers, resulting in 
increased ischemic heart infarct size and heart 
dysfunction. Of importance, inhibition of autophagy 
via 3-MA rescued nicotine-mediated pathological 
effects and heart dysfunctions. These findings not 
only provide novel evidence regarding the molecular 
mechanisms underlying nicotine-induced ischemic 
heart injury and dysfunction, but also suggest a 
potential therapeutic molecular target of autophagy 
involved in the setting of ischemic heart disease.  
Future studies 
In our present study we have demonstrated that 
chronic nicotine exposure enhances I/R-induced 
heart dysfunction associated with an excessive 
autophagy flux. However, one of the limitations for 
this study is unknown whether the induction of the 
autophagy proteins is directly regulated by nicotine 
exposure or I/R procedure. Therefore, in our future 
study we should measure the basal levels of 
autophagy influx in the control and nicotine-treated 
animals to see whether nicotine-mediated pre-existed 
increase of autophagy in the heart would exacerbate 
the ischemic/reperfusion injury. While infarct size 
and cardiac function are good indicators of 
myocardial ischemia/reperfusion injury, other 
indicators such as Troponin I concentration can 
further support the claim. Thus, in our future studies, 
we will investigate whether nicotine exposure affects 
Troponin I expression in response to I/R. It’s well 
known that 3-MA is a selective autophagy/PI3K 
inhibitor. However, 3-MA could induce potential 
non-specific effects on heart function. It depends on 
the patho-physiologic condition of the animals and 
dosage of 3-MA. For instance, previous studies have 
reported that 3-MA has dual role in modulation of 
autophagy and induces an autophagic promotion 
effect under nutrient-rich condition [53]. Moreover, 
3-MA can inhibit tumor metastasis in an 
autophagy-independent manner [54]. Furthermore, 
3-MA has an anti-inflammatory effect in 
atherosclerosis [55]. Therefore, further investigation is 
needed to unmask the diverse regulations of 3-MA on 
nicotine-mediated heart I/R injury and dysfunction. 
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